Loading...
Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis | NEJM Clinician
NEJM Research Summary
Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis
New England Journal of Medicine
Dec 22, 2025
1 min read
New England Journal of Medicine
December 22, 2025
1 min read
New England Journal of Medicine
December 22, 2025
1 min read
Related Content
Journal Watch
Does High-Dose Rifampin Improve Tuberculous Meningitis Outcomes?
Original Article
Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis
Topics
Infectious Disease
Infectious Disease General
HIV/AIDS
Tuberculosis
Global Health